Tissueblue

Active Ingredient(s): Brilliant Blue G
FDA Approved: * December 20, 2019
Pharm Company: * DUTCH OPHTHALMIC RESEARCH
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Tissueblue Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Brilliant Blue G
  • Solution: 0.025%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tissueblue: (1 result)

Sorted by National Drug Code
  • 68803-722 Tissueblue .0125 mg/.5ml Intraocular; Ophthalmic Injection, Solution by D.o.r.c. Dutch Ophthalmic Research Center (International) B.v.



Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA